Literature DB >> 28269960

Evaluating a Novel Summary Visualization for Clinical Trial Reports: A Usability Study.

Maurine Tong1, William Hsu1, Ricky K Taira1.   

Abstract

Contributions of clinical trials are captured in published reports that are unstructured and often require extensive manual review to gain a deeper understanding of the study itself. Our goal is to increase comprehension and decrease the time necessary to understand these reports through the use of visualization tools. In this paper, we specify and evaluate the visualization of a previously developed representation as well as gain insight from user input for further development. The usability experiment consisted of a two-arm study with users either having or not having access to the visualization. A user questionnaire was used to measure time spent and accuracy in comprehension; intuitiveness and reproducibility of the visualization; and preferences. We found that having the visualization required on average 28.1% less time (25.8 min vs. 35.8 min, p=0.01) while maintaining similar accuracy (73.7% vs. 67.0%). Users were then asked to create their own visualizations, with their visualizations averaging 86.1% similar to the gold standard. All participants either preferred the visualization over the status quo or preferred both equally. These results demonstrate that novel visualizations for trial reports could provide time savings and achieve similar accuracy as reviewing the paper itself. Understanding the strength and quality of clinical trials can be alleviated with a visualization that makes content explicit.

Entities:  

Mesh:

Year:  2017        PMID: 28269960      PMCID: PMC5333215     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  15 in total

1.  The Trial Bank system: capturing randomized trials for evidence-based medicine.

Authors:  Ida Sim; Ben Olasov; Simona Carini
Journal:  AMIA Annu Symp Proc       Date:  2003

2.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

3.  Implementing community-based standards of care.

Authors:  Paul N Urick
Journal:  J Manag Care Pharm       Date:  2005-05

4.  Automated extraction of reported statistical analyses: towards a logical representation of clinical trial literature.

Authors:  William Hsu; William Speier; Ricky K Taira
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

5.  It's NOT FAIR! Or is it? The promise and the tyranny of evidence-based performance assessment.

Authors:  Elizabeth Bogdan-Lovis; Leonard Fleck; Henry C Barry
Journal:  Theor Med Bioeth       Date:  2012-08

6.  How to report a research study.

Authors:  Paul Cronin; James V Rawson; Marta E Heilbrun; Janie M Lee; Aine M Kelly; Pina C Sanelli; Brian W Bresnahan; Angelisa M Paladin
Journal:  Acad Radiol       Date:  2014-09       Impact factor: 3.173

7.  Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.

Authors:  Wolfram Brugger; Nadja Triller; Maria Blasinska-Morawiec; Stefan Curescu; Raimundas Sakalauskas; Georgy Moiseevich Manikhas; Julien Mazieres; Renaud Whittom; Carol Ward; Karen Mayne; Kerstin Trunzer; Federico Cappuzzo
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

8.  First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

Authors:  Lecia V Sequist; Renato G Martins; David Spigel; Steven M Grunberg; Alexander Spira; Pasi A Jänne; Victoria A Joshi; David McCollum; Tracey L Evans; Alona Muzikansky; Georgiana L Kuhlmann; Moon Han; Jonathan S Goldberg; Jeffrey Settleman; A John Iafrate; Jeffrey A Engelman; Daniel A Haber; Bruce E Johnson; Thomas J Lynch
Journal:  J Clin Oncol       Date:  2008-05-05       Impact factor: 44.544

9.  Improving the accuracy of therapy descriptions in clinical trials using a bottom-up approach.

Authors:  Maurine Tong; Ricky K Taira
Journal:  AMIA Annu Symp Proc       Date:  2012-11-03

10.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer.

Authors:  David H Johnson; Louis Fehrenbacher; William F Novotny; Roy S Herbst; John J Nemunaitis; David M Jablons; Corey J Langer; Russell F DeVore; Jacques Gaudreault; Lisa A Damico; Eric Holmgren; Fairooz Kabbinavar
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  1 in total

1.  Interactive Visual Displays for Interpreting the Results of Clinical Trials: Formative Evaluation With Case Vignettes.

Authors:  Jiantao Bian; Charlene Weir; Prasad Unni; Damian Borbolla; Thomas Reese; Yik-Ki Jacob Wan; Guilherme Del Fiol
Journal:  J Med Internet Res       Date:  2018-06-25       Impact factor: 5.428

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.